30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Melinta Therapeutics Inc (MLNTQ)

Track

Stock chart
Ticker: MLNTQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
JOHNSON JOHN
Chief Executive Officer
1 sale — total 72,441 USD
Sale 27 Jun 2019
Value US$2,197,856.47 | Price 189.31 | Shares 90,517
Buy 29 May 2018
Value US$2,285,156.09 | Price 393.22 | Shares 45,862
Buy 29 May 2018
Value US$200,000.00 | Price 5.00 | Shares 40,000
Buy 29 May 2018
Value US$250,000.00 | Price 5.00 | Shares 50,000
Buy 29 May 2018
Value US$20,000.00 | Price 5.00 | Shares 4,000
Buy 29 May 2018
Value US$50,000.00 | Price 5.00 | Shares 10,000
Buy 29 May 2018
Value US$39,392,500.00 | Price 5.00 | Shares 7,878,500
Buy 29 May 2018
Value US$39,392,500.00 | Price 5.00 | Shares 7,878,500
Buy 29 May 2018
Value US$37,500,000.00 | Price 5.00 | Shares 7,500,000
Buy 25 May 2018
Value US$30,450.00 | Price 6.09 | Shares 5,000
Buy 5 Jan 2018
Value US$27,000,000.00 | Price 13.50 | Shares 2,000,000
Buy 5 Jan 2018
Value US$27,000,000.00 | Price 13.50 | Shares 2,000,000
Buy 5 Jan 2018
Value US$24,000,003.00 | Price 13.50 | Shares 1,777,778
Sale 8 Mar 2017
Value US$356,443.20 | Price 3.57 | Shares 99,900
Sale 7 Mar 2017
Value US$176,672.64 | Price 3.53 | Shares 50,100
Sale 13 Jan 2017
Value US$358,564.00 | Price 3.40 | Shares 105,460
Sale 6 Jan 2017
Value US$1,592,864.00 | Price 3.64 | Shares 437,600
Sale 5 Jan 2017
Value US$1,600,000.00 | Price 3.20 | Shares 500,000
Buy 3 Jan 2017
Value US$14,720.00 | Price 2.94 | Shares 5,000
Buy 1 Mar 2016
Value US$8,090.00 | Price 16.18 | Shares 500
Planned sale 4 Jan 2016
Value US$25,314.48 | Price 30.06 | Shares 842
Planned sale 15 Dec 2015
Value US$53,340.00 | Price 30.00 | Shares 1,778
Planned sale 11 Dec 2015
Value US$249,373.26 | Price 30.33 | Shares 8,222
Sale 9 Nov 2015
Value US$63,316.00 | Price 28.78 | Shares 2,200
Sale 9 Nov 2015
Value US$287,800.00 | Price 28.78 | Shares 10,000
Buy 26 Oct 2015
Value US$36,896.00 | Price 18.45 | Shares 2,000
Buy 26 Oct 2015
Value US$49,335.39 | Price 17.43 | Shares 2,830
Planned sale 22 Jun 2015
Value US$1,787,000.00 | Price 35.74 | Shares 50,000
Sale 22 May 2015
Value US$321,489.00 | Price 35.72 | Shares 9,000
Buy 23 May 2014
Value US$90,980.00 | Price 9.10 | Shares 10,000
Buy 19 Jun 2013
Value US$1,855,000.00 | Price 7.00 | Shares 265,000
Buy 19 Jun 2013
Value US$1,855,000.00 | Price 7.00 | Shares 265,000
Buy 9 May 2013
Value US$30,100.00 | Price 8.60 | Shares 3,500
Buy 8 Feb 2012
Value US$6,150.00 | Price 6.00 | Shares 1,025
Buy 8 Feb 2012
Value US$100,002.00 | Price 6.00 | Shares 16,667
Buy 8 Feb 2012
Value US$6,150.00 | Price 6.00 | Shares 1,025
Buy 8 Feb 2012
Value US$99,996.00 | Price 6.00 | Shares 16,666
Buy 8 Feb 2012
Value US$6,150.00 | Price 6.00 | Shares 1,025
Buy 8 Feb 2012
Value US$99,996.00 | Price 6.00 | Shares 16,666
Buy 8 Feb 2012
Value US$6,150.00 | Price 6.00 | Shares 1,025
Buy 8 Feb 2012
Value US$100,002.00 | Price 6.00 | Shares 16,667
Buy 8 Feb 2012
Value US$4,397,934.00 | Price 6.00 | Shares 732,989
Buy 8 Feb 2012
Value US$2,931,954.00 | Price 6.00 | Shares 488,659
Buy 8 Feb 2012
Value US$7,138,830.00 | Price 6.00 | Shares 1,189,805
Buy 7 Feb 2012
Value US$7,281,978.00 | Price 6.00 | Shares 1,213,663
Buy 7 Feb 2012
Value US$7,281,978.00 | Price 6.00 | Shares 1,213,663
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-07-02 2019-06-27 S Sale
3.2
JOHNSON JOHN

Chief Executive Officer

Executive Director
90,517 -38.9%
189.31
US$2,197,856 		90,517 -38.9% 189.31 US$2,197,856
2018-05-31 2018-05-29 B Purchase Duffy Erin

Chief Scientific Officer

Officer
45,862 +12.5%
393.22
US$2,285,156 		45,862 +12.5% 393.22 US$2,285,156
2018-05-31 2018-05-29 B Purchase ZACCARDELLI DAVID Non-Executive Director
67,632 -11.7%
202.69
US$897,541 		67,632 -11.7% 202.69 US$897,541
2018-05-31 2018-05-29 B Purchase Wechsler Daniel Mark

See Remarks

Executive Director
50,000 +inf%
5.00
US$250,000 		50,000 +inf% 5.00 US$250,000
2018-05-31 2018-05-29 B Purchase Cammarata Sue

Chief Medical Officer

Officer
4,000 +inf%
5.00
US$20,000 		4,000 +inf% 5.00 US$20,000
2018-05-31 2018-05-29 B Purchase Estrem Paul

Chief Financial Officer

Officer
10,000 +inf%
5.00
US$50,000 		10,000 +inf% 5.00 US$50,000
2018-05-31 2018-05-29 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
7,878,500 +90.3%
5.00
US$39,392,500 		7,878,500 +90.3% 5.00 US$39,392,500
2018-05-31 2018-05-29 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
7,878,500 +90.3%
5.00
US$39,392,500 		7,878,500 +90.3% 5.00 US$39,392,500
2018-05-31 2018-05-29 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
7,500,000 +88.2%
5.00
US$37,500,000 		7,500,000 +88.2% 5.00 US$37,500,000
2018-05-30 2018-05-25 B Purchase GILL DAVID N Non-Executive Director
5,000 +500.0%
6.09
US$30,450 		5,000 +500.0% 6.09 US$30,450
2018-01-09 2018-01-05 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
2,000,000 +29.7%
13.50
US$27,000,000 		2,000,000 +29.7% 13.50 US$27,000,000
2018-01-09 2018-01-05 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
2,000,000 +29.7%
13.50
US$27,000,000 		2,000,000 +29.7% 13.50 US$27,000,000
2018-01-09 2018-01-05 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
1,777,778 +26.4%
13.50
US$24,000,003 		1,777,778 +26.4% 13.50 US$24,000,003
2017-03-09 2017-03-08 S Sale GOLDSTEIN DOV A MD Non-Executive Director
99,900 -100.0%
3.57
US$356,443 		99,900 -100.0% 3.57 US$356,443
2017-03-09 2017-03-07 S Sale GOLDSTEIN DOV A MD Non-Executive Director
50,100 -33.4%
3.53
US$176,673 		50,100 -33.4% 3.53 US$176,673
2017-01-18 2017-01-13 S Sale GOLDSTEIN DOV A MD Non-Executive Director
105,460 -41.3%
3.40
US$358,564 		105,460 -41.3% 3.40 US$358,564
2017-01-06 2017-01-06 S Sale GOLDSTEIN DOV A MD Non-Executive Director
437,600 -63.1%
3.64
US$1,592,864 		437,600 -63.1% 3.64 US$1,592,864
2017-01-06 2017-01-05 S Sale GOLDSTEIN DOV A MD Non-Executive Director
500,000 -41.9%
3.20
US$1,600,000 		500,000 -41.9% 3.20 US$1,600,000
2017-01-04 2017-01-03 B Purchase GILL DAVID N Non-Executive Director
5,000 +inf%
2.94
US$14,720 		5,000 +inf% 2.94 US$14,720
2016-03-02 2016-03-01 B Purchase Moore David

Chief Commercial Officer

Officer
500 +50.0%
16.18
US$8,090 		500 +50.0% 16.18 US$8,090
2016-01-06 2016-01-04 PlS Planned sale GOLDSTEIN DOV A MD Non-Executive Director
842 -94.4%
30.06
US$25,314 		842 -94.4% 30.06 US$25,314
2015-12-15 2015-12-15 PlS Planned sale Oldach David W.

Chief Medical Officer

Officer
1,778 -61.8%
30.00
US$53,340 		1,778 -61.8% 30.00 US$53,340
2015-12-15 2015-12-11 PlS Planned sale Oldach David W.

Chief Medical Officer

Officer
8,222 -88.2%
30.33
US$249,373 		8,222 -88.2% 30.33 US$249,373
2015-11-12 2015-11-09 S Sale Oldach David W.

Chief Medical Officer

Officer
2,200 -66.7%
28.78
US$63,316 		2,200 -66.7% 28.78 US$63,316
2015-11-12 2015-11-09 S Sale Oldach David W.

Chief Medical Officer

Officer
10,000 -75.2%
28.78
US$287,800 		10,000 -75.2% 28.78 US$287,800
2015-10-27 2015-10-26 B Purchase DOUGHERTY MICHAEL R Non-Executive Director
2,000 +inf%
18.45
US$36,896 		2,000 +inf% 18.45 US$36,896
2015-10-26 2015-10-26 B Purchase Kong Garheng Non-Executive Director
2,830 +inf%
17.43
US$49,335 		2,830 +inf% 17.43 US$49,335
2015-06-24 2015-06-22 PlS Planned sale GOLDSTEIN DOV A MD Non-Executive Director
50,000 -99.9%
35.74
US$1,787,000 		50,000 -99.9% 35.74 US$1,787,000
2015-05-27 2015-05-22 S Sale Fernandes Prabhavathi

President and CEO

Executive Director
9,000 -3.5%
35.72
US$321,489 		9,000 -3.5% 35.72 US$321,489
2014-05-28 2014-05-23 B Purchase JOHNSON JOHN Non-Executive Director
10,000 +inf%
9.10
US$90,980 		10,000 +inf% 9.10 US$90,980
2013-08-01 2013-06-19 B Purchase NEFF P SHERRILL Non-Executive Director
265,000 +8.1%
7.00
US$1,855,000 		265,000 +8.1% 7.00 US$1,855,000
2013-08-01 2013-06-19 B Purchase Quaker BioVentures II LP Large shareholder
265,000 +8.1%
7.00
US$1,855,000 		265,000 +8.1% 7.00 US$1,855,000
2014-05-13 2013-05-09 B Purchase Fernandes Prabhavathi

President and CEO

Executive Director
3,500 +1.7%
8.60
US$30,100 		3,500 +1.7% 8.60 US$30,100
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.2%
6.00
US$6,150 		1,025 +0.2% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,667 +3.5%
6.00
US$100,002 		16,667 +3.5% 6.00 US$100,002
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.2%
6.00
US$6,150 		1,025 +0.2% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,666 +3.6%
6.00
US$99,996 		16,666 +3.6% 6.00 US$99,996
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.2%
6.00
US$6,150 		1,025 +0.2% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,666 +3.3%
6.00
US$99,996 		16,666 +3.3% 6.00 US$99,996
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.1%
6.00
US$6,150 		1,025 +0.1% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,667 +2.3%
6.00
US$100,002 		16,667 +2.3% 6.00 US$100,002
2012-02-09 2012-02-08 B Purchase Intersouth Associates VI, LLC Large shareholder
732,989 +119.7%
6.00
US$4,397,934 		732,989 +119.7% 6.00 US$4,397,934
2012-02-09 2012-02-08 B Purchase NEFF P SHERRILL Non-Executive Director Large shareholder
1,189,805 +57.4%
6.00
US$7,138,830 		1,189,805 +57.4% 6.00 US$7,138,830
2012-02-09 2012-02-08 B Purchase Intersouth Associates VI, LLC Large shareholder
488,659 +33.0%
6.00
US$2,931,954 		488,659 +33.0% 6.00 US$2,931,954
2012-02-09 2012-02-07 B Purchase Aisling Capital II LP Large shareholder
1,213,663 +58.4%
6.00
US$7,281,978 		1,213,663 +58.4% 6.00 US$7,281,978
2012-02-09 2012-02-07 B Purchase GOLDSTEIN DOV A MD Non-Executive Director
1,213,663 +58.4%
6.00
US$7,281,978 		1,213,663 +58.4% 6.00 US$7,281,978
Explore more

More insider trading research around Melinta Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America